CD8A and cancer: Interestingly, in the same study, cyclophosphamide treatment of tumour-bearing mice, which induces the translocation of E. hirae from the gut lumen to the mesenteric and splenic immune tissues, resulted in improved anti-cancer CD8+ T cell responses.